Sarepta Therapeutics Inc
XMUN:AB3A
Sarepta Therapeutics Inc
XMUN:AB3A
Price:
15.3
EUR
4.22%
Market Closed
Market Cap:
€950.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
|
B
|
Bank of New York Mellon Corp
XMUN:BN9
|
US |
|
H
|
HSBC Holdings PLC
XMUN:HBC2
|
UK |
|
VG Life Sciences Inc
OTC:VGLS
|
US |
|
C
|
CompuGroup Medical SE & Co KgaA
LSE:0MSD
|
DE |
|
L
|
Lockheed Martin Corp
LSE:0R3E
|
US |
|
B
|
Banco Santander SA
VSE:SAN
|
ES |
|
K
|
Komercni Banka as
XMUN:KONN
|
CZ |
|
Telekom Austria AG
LSE:0NKL
|
AT |
|
K
|
Koninklijke Philips NV
XETRA:PHI1
|
NL |
|
R
|
Relx PLC
F:RDED
|
UK |
Multiples-Based Value
The Multiples-Based Value for 
Sarepta Therapeutics Inc (AB3A) under the Base Case is hidden
EUR.
Compared with the current market price of 15.3 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AB3A Multiples-Based Value
LOCKED
